ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268925; 2) Community: the network communities that were significantly associated with the response to NSC 268925; 3) Molecule: the relationships between components within communities and NSC 268925; 4) MDR: the compounds that were significantly associated with the NSC 268925.

NSC Compound Enrichment Correlation
NSC 1390 Allopurinol 0.0162638908166157 -0.12786482
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0162638908166157 -0.27946463
NSC 374979 Null 0.0162638908166157 0.36358642
NSC 638487 (Z) 4-Acetoxy-(3,4',5)-trimethoxystilbene 0.0162638908166157 0.47582398
NSC 648365 Insulin-Methotrexate conjugate 0.0162638908166157 0.393373
NSC 658455 (S,S)(-)3,5-Dimethoxy N-(.alpha.-Phenethyl)phenyl isopropylamine 0.0162638908166157 0.09937158
NSC 676343 Null 0.0162638908166157 -0.034891848
NSC 676676 ARQ monoacetate 0.0162638908166157 0.40219962
NSC 712396 Phosphine, [2-(dipyridinylphosphino)ethyl]diphenyl- 0.0162638908166157 0.24494567
NSC 712742 Null 0.0162638908166157 0.21759532
Total:44  Current:11    [First] [Prev] [Next] [Last]